Mycobacterial Metabolism and Antibiotic Research Laboratory, The Francis Crick Institute, London NW1 1AT, United Kingdom.
Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.
Biochemistry. 2021 Nov 30;60(47):3621-3632. doi: 10.1021/acs.biochem.1c00672. Epub 2021 Nov 15.
Methionine adenosyltransferase (MAT) catalyzes the adenosine 5'-triphosphate (ATP) and l-methionine (l-Met) dependent formation of -adenosyl-l-methionine (SAM), the principal methyl donor of most biological transmethylation reactions. We carried out in-depth kinetic studies to further understand its mechanism and interaction with a potential regulator, Mat2B. The initial velocity pattern and results of product inhibition by SAM, phosphate, and pyrophosphate, and dead-end inhibition by the l-Met analog cycloleucine (l-cLeu) suggest that Mat2A follows a strictly ordered kinetic mechanism where ATP binds before l-Met and with SAM released prior to random release of phosphate and pyrophosphate. Isothermal titration calorimetry (ITC) showed binding of ATP to Mat2A with a of 80 ± 30 μM, which is close to the of 50 ± 10 μM. In contrast, l-Met or l-cLeu showed no binding to Mat2A in the absence of ATP; however, binding to l-cLeu was observed in the presence of ATP. The ITC results are fully consistent with the product and dead-inhibition results obtained. We also carried out kinetic studies in the presence of the physiological regulator Mat2B. Under conditions where all Mat2A is found in complex with Mat2B, no significant change in the kinetic parameters was observed despite confirmation of a very high binding affinity of Mat2A to Mat2B ( of 6 ± 1 nM). Finally, we found that while Mat2A is unstable at low concentrations (<100 nM), rapidly losing activity at 37 °C, it retained full activity for at least 2 h when Mat2B was present at the known 2:1 Mat2A/Mat2B stoichiometry.
甲硫氨酸腺苷转移酶(MAT)催化腺苷 5'-三磷酸(ATP)和 l-甲硫氨酸(l-Met)依赖性 - 腺苷 - l-甲硫氨酸(SAM)的形成,SAM 是大多数生物转甲基反应的主要甲基供体。我们进行了深入的动力学研究,以进一步了解其机制及其与潜在调节剂 Mat2B 的相互作用。SAM、磷酸盐和焦磷酸盐的产物抑制以及 l-Met 类似物环亮氨酸(l-cLeu)的无活力抑制的初始速度模式和结果表明,Mat2A 遵循严格的有序动力学机制,其中 ATP 在 l-Met 之前结合,并且在随机释放磷酸盐和焦磷酸盐之前释放 SAM。等温滴定量热法(ITC)显示 ATP 与 Mat2A 的结合具有 80 ± 30 μM 的 ,接近 50 ± 10 μM 的 。相比之下,在没有 ATP 的情况下,l-Met 或 l-cLeu 均未与 Mat2A 结合;然而,在存在 ATP 的情况下观察到与 l-cLeu 的结合。ITC 结果与获得的产物和无活力抑制结果完全一致。我们还在生理调节剂 Mat2B 的存在下进行了动力学研究。在所有 Mat2A 都与 Mat2B 形成复合物的条件下,尽管证实了 Mat2A 与 Mat2B 的高结合亲和力( 为 6 ± 1 nM),但动力学参数没有明显变化。最后,我们发现虽然 Mat2A 在低浓度(<100 nM)下不稳定,在 37°C 下迅速失去活性,但当 Mat2B 存在于已知的 2:1 Mat2A/Mat2B 比例时,它至少保持 2 小时的完全活性。